SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Ajootian who wrote (3480)7/23/1999 9:30:00 AM
From: Biomaven  Read Replies (1) of 10280
 
Q2 results out - Xopenex sales of $4.2m, which is more than I was guessing - those scrip numbers are deceptive. Initial sales are always tricky because of stocking, but I am guessing that Xopenex wouldn't get automatically stocked unless someone wanted to use it or it got added to a formulary.

We really need a couple of quarters to get a better handle, but this is an encouraging beginning. Lehman's recent projection is $30m for '99.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News